The German shepherd is one of the UK’s most popular dog breeds, celebrated for its size, versatility, and intelligence. This breed excels in various roles including as loyal family pets, assistance dogs, and competitors in canine sports due to their trainability and responsiveness.
However, German shepherds have been selectively bred over many decades, which has introduced some hereditary health concerns. Among these is leukocyte adhesion deficiency type III (LAD III), a serious inherited immune disorder. Selecting healthy dogs and using DNA testing to screen for hereditary conditions is vital to maintaining the health and welfare of the breed.
LAD III is an inherited blood disorder caused by a mutation in the FERMT3 gene. This genetic mutation impairs the function of white blood cells (leukocytes), preventing them from properly migrating to the sites of infections or injury. As a result, affected German shepherds suffer from recurrent, persistent infections that do not respond well to antibiotics.
Although dogs with LAD III often look healthy, even minor wounds or bruising fail to heal properly due to compromised immune response and the blood's reduced ability to clot. This condition can make surgery risky for affected dogs, often requiring blood transfusions during procedures.
The disease is inherited in an autosomal recessive pattern. This means a dog must inherit two copies of the mutated gene (one from each parent) to be affected. Dogs with only one copy are carriers and typically healthy, but they can pass the mutation on to their offspring.
The inheritance patterns between parent dogs affect the status of puppies born:
To promote responsible breeding and reduce the incidence of LAD III in German shepherds, DNA testing is recommended for all breeder dogs. Testing identifies whether a dog is clear, a carrier, or affected with the mutation.
Testing involves a simple collection of a DNA sample by your vet, usually via a blood sample in EDTA tube or cheek swabs. The sample is sent to a specialist laboratory such as Laboklin in the UK, which offers a PCR or sequencing-based test for the FERMT3 mutation. Results generally take 7 to 14 working days.
Knowing the genetic status of breeding dogs allows breeders to avoid mating two carriers or an affected dog, thus preventing pups with LAD III and improving overall breed health.
Breeders should use LAD III DNA test results to guide mating decisions:
This responsible approach helps to balance genetic health and diversity while working toward reducing the presence of LAD III in the population.
Leukocyte adhesion deficiency type III is a serious, inherited immune disorder in German shepherds that affects their ability to fight infections and heal wounds. DNA testing for LAD III is a vital tool for breeders committed to producing healthy puppies and managing breed health responsibly.
If you are considering finding a German shepherd puppy or are a breeder planning a litter, ask your vet about LAD III DNA testing to protect your dogs and puppies from this hereditary condition.